Henderson Molly — SEC Form 4 filings
SEC reporting owner CIK 1363812. 8 Form 4 filings on record with FilingPulse; latest filed 2025-04-08.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-22 to 2025-04-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 25,619 shares, $208,156 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 4,325 shares @ $11.72 ($50,689) in Phathom Pharmaceuticals, Inc., filed 2024-07-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | CFO and CBO | 8 | — | 6 legs · 25,619 sh · $208,156 | 4 |
Form 4 filings — Henderson Molly
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-08 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 3,678 @ $4.55 | EDGAR |
| 2025-03-03 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 72,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 6,583 @ $6.59 | EDGAR |
| 2024-12-20 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 1,291 @ $8 | EDGAR |
| 2024-07-17 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 4,325 @ $11.72 | EDGAR |
| 2024-05-31 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 7,500 @ $0 | EDGAR |
| 2024-04-10 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 3,435 @ $11.10 | EDGAR |
| 2024-01-22 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 6,307 @ $7.75 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1363812 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →